US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Jetson Electric Bikes Recalls 42-Volt Rogue Self-Balancing Scooters/Hoverboards Due to Fire Hazard; Two Deaths Reported

      The lithium-ion battery packs in the self-balancing scooters/hoverboards can overheat, posing a fire hazard. … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

January 5, 2019 By The FDA Leave a Comment

Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and 3 lots of Ceftriaxone for Injection, USP 2g, to the hospital/physician level. The products have been found to contain visual grey particulate matter in reconstituted vials.

Improper piercing and use of a needle greater than 21 gauge (larger internal diameter), while reconstituting the vial, can push rubber flecks into the solution. There were no grey flecks seen prior to the reconstitution of the vials and the issue was identified upon standard visual inspection prior to patient administration.

If injected, this product (containing rubber particulate matter from the stopper) could cause vein irritation/phlebitis or pulmonary embolic events that could result in permanent impairment of body function or damage to body structures, such as the lungs and vascular system. In addition, as ceftriaxone can be administered intramuscularly, the use of the product may result in local muscle inflammation and/or abscesses.

Ceftriaxone for Injection, USP, is used as a sterile, semi-synthetic, broad-spectrum cephalosporin antibiotic for intravenous or intramuscular administration. It is used to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone sodium and other antibacterial drugs Ceftriaxone for Injection, USP, should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. To date, the Company has not received any reports of adverse events related to the recalled lots.

Ceftriaxone for Injection, USP, is packaged in a glass vial, in pack of 10, containing 10 vials in a carton, with NDC 68180-611-10, 68180-622-10, 68180-633-10, 68180-644-10 and as single pack containing one glass vial in a carton with NDC 68180-611-01, 68180-622-01, 68180-633-01.

The lots of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g included in the recall are listed in the table below:

Product Name NDC Lot Number Expiration Date
Ceftriaxone for Injection USP, 250mg 68180-611-10 C600182 09/2019
68180-611-10 C600136 08/2019
68180-611-01 C600142 08/2019
68180-611-10 C700147 05/2020
68180-611-10 C700207 09/2020
Ceftriaxone for Injection USP, 500mg 68180-622-01 C600218 09/2019
68180-622-10 C600219 09/2019
68180-622-10 C600126 08/2019
68180-622-10 C600127 08/2019
68180-622-10 C600137 08/2019
68180-622-10 C600143 08/2019
68180-622-01 C600173 08/2019
68180-622-10 C700146 05/2020
68180-622-10 C700208 09/2020
68180-622-10 C700209 09/2020
Ceftriaxone for Injection USP, 1g 68180-633-10 C600106 05/2019
68180-633-10 C600108 05/2019
68180-633-01 C600110 05/2019
68180-633-10 C600174 09/2019
68180-633-10 C600179 09/2019
68180-633-10 C600180 09/2019
68180-633-10 C600181 09/2019
68180-633-10 C700110 03/2020
68180-633-10 C700111 03/2020
68180-633-10 C700131 05/2020
68180-633-10 C700132 05/2020
68180-633-10 C700138 05/2020
68180-633-01 C700143 05/2020
68180-633-10 C600128 08/2019
68180-633-01 C600130 08/2019
68180-633-10 C600138 08/2019
68180-633-10 C700108 03/2020
68180-633-10 C700109 03/2020
68180-633-10 C700112 03/2020
68180-633-10 C700129 05/2020
68180-633-10 C700130 05/2020
68180-633-10 C700142 05/2020
68180-633-10 C700145 05/2020
68180-633-01 C700113 03/2020
Ceftriaxone for Injection USP, 2g 68180-644-10 C600109 05/2019
68180-644-10 C600129 08/2019
68180-644-10 C600135 08/2019

Ceftriaxone for Injection, USP, 250mg, Ceftriaxone for Injection, USP, 500mg, Ceftriaxone for Injection, USP, 1g and Ceftriaxone for Injection, USP, 2g were distributed Nationwide to Wholesalers / Drug chains.

Lupin Pharmaceuticals Inc. is notifying its distributors by phone and through recall notification and is arranging for return of all recalled product lots.

Hospitals / Physicians that have Ceftriaxone for Injection, USP, which are being recalled should stop using and return to Genco Pharmaceuticals Services “a subsidiary of FedEx Supply Chain” 6101 North 64th Street, Milwaukee, WI 53218, Tel: (855) 838-5786.

Questions regarding this recall can be made by contacting GENCO Pharmaceutical Services at 1-855-838-5786 Monday – Friday 7:30 am to 6:00 pm EST. For reimbursement, please have the recalled lots returned to GENCO, the lot number can be found on the side of the vial. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

###

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Jetson Electric Bikes Recalls 42-Volt Rogue Self-Balancing Scooters/Hoverboards Due to Fire Hazard; Two Deaths Reported

March 29, 2023 By The CPSC

Delta Enterprise Corp. Recalls 2-in-1 Outdoor Kids Swings Due to
Fall Hazard

March 29, 2023 By The CPSC

Lexmark Ventures Recalls Solexio Hair Stylers Due to Electrocution or Shock Hazard

March 29, 2023 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Cannondale Recalls Tesoro Neo X Speed Electric Bicycles Due to Fall and Injury Hazards

March 29, 2023 By The CPSC

JBM International Electric Recalls Adult Bike Helmets Due to Risk of Head Injury; Sold Exclusively on Amazon.com (Recall Alert)

March 29, 2023 By The CPSC

Higdon Outdoors Recalls Battery Packs on XS Series Motion Waterfowl Decoys and Replacement Battery Packs Due to Fire and/or Burn Hazards

March 29, 2023 By The CPSC

Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites

March 29, 2023 By The FDA

North American Food Distributing Company, Inc. Issues Allergy Alert on Undeclared Soy in 16.9 Fl Oz of Kagome Worcester Sauce and 16.9 Fl Oz of Kagome Chuno Sauce

March 27, 2023 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites

March 29, 2023 By The FDA

North American Food Distributing Company, Inc. Issues Allergy Alert on Undeclared Soy in 16.9 Fl Oz of Kagome Worcester Sauce and 16.9 Fl Oz of Kagome Chuno Sauce

March 27, 2023 By The FDA

Gilster-Mary Lee Corp. Issues a Recall for Undeclared Milk Allergen in HyVee Hamburger Chili Macaroni Skillet Meal

March 27, 2023 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Jetson Electric Bikes Recalls 42-Volt Rogue Self-Balancing Scooters/Hoverboards Due to Fire Hazard; Two Deaths Reported
  • Delta Enterprise Corp. Recalls 2-in-1 Outdoor Kids Swings Due to
    Fall Hazard
  • Lexmark Ventures Recalls Solexio Hair Stylers Due to Electrocution or Shock Hazard
  • Carhartt Recalls Men’s Work Pants with Hem Adjustment Cords Due to Fall Hazard; Sold Exclusively at Dick’s Sporting Goods
  • Bicycles and Framesets Recalled Due to Crash Hazard; Manufactured by Open Cycle
  • Cannondale Recalls Tesoro Neo X Speed Electric Bicycles Due to Fall and Injury Hazards
  • JBM International Electric Recalls Adult Bike Helmets Due to Risk of Head Injury; Sold Exclusively on Amazon.com (Recall Alert)
  • Higdon Outdoors Recalls Battery Packs on XS Series Motion Waterfowl Decoys and Replacement Battery Packs Due to Fire and/or Burn Hazards
  • Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in